Engineered T cells
US-12590136-B2 · Mar 31, 2026 · US
Sommermeyer Daniel is listed as an inventor on 7 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Sommermeyer Daniel |
| Total patents | 7 |
| First publication | Jul 11, 2019 |
| Latest publication | Mar 31, 2026 |
Publications ranked by popularity score, then publication date.
US-12590136-B2 · Mar 31, 2026 · US
US-2025346648-A1 · Nov 13, 2025 · US
US-12344654-B2 · Jul 1, 2025 · US
US-2024279307-A1 · Aug 22, 2024 · US
US-2020231649-A1 · Jul 23, 2020 · US
US-10538574-B2 · Jan 21, 2020 · US
US-2019211076-A1 · Jul 11, 2019 · US
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Hutchinson Fred Cancer Res | 3 |
| Medigene Immunotherapies Gmbh | 3 |
| Regeneron Pharma | 3 |
| Fred Hutchinson Cancer Center | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N2510/00 | 7 |
| A61P35/02 | 7 |
| C07K14/7051 | 7 |
| A61K35/17 | 7 |
| C12N5/0636 | 7 |